Good morning, trader! It’s time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday!
We’ve got SPAC mergers, earnings reports, FDA updates, and more moving stocks this morning.
Let’s get right into that news below!
Pre-Ҵý Stock Movers: 10 Top Gainers
- Ensysce Biosciences (NASDAQ:ENSC) stock is rocketing more than 52% .
- Pear Therapeutics (NASDAQ:PEAR) shares are surging close to 34% .
- American Virtual Cloud (NASDAQ:AVCT) stock is soaring over 24% .
- Siyata Mobile (NASDAQ:SYTA) shares are rising more than 23% as shares experience volatility following a massive purchase agreement earlier this week.
- Redhill Biopharma (NASDAQ:RDHL) stock is climbing over 13% .
- Restoration Hardware (NYSE:RH) shares are increasing nearly 11% .
- Eros STX Global (NYSE:ESGC) stock is gaining more than 9% .
- Nuvei (NASDAQ:NVEI) shares are jumping over 8% .
- First High-School Edu (NYSE:FHS) stock is getting a roughly 8% boost despite a lack of news this morning.
- Aurinia Pharmaceuticals (NASDAQ:AUPH) shares are up 8% .
10 Top Losers
- Reata Pharmaceuticals (NASDAQ:RETA) stock is plummeting 43% .
- Code Chain New Continent (NASDAQ:CCNC) shares are diving more than 41% after trending higher the last few days.
- Triterras (NASDAQ:TRIT) stock is taking an over 16% beating .
- AGM Group Holdings (NASDAQ:AGMH) shares are falling more than 13% .
- Rent the Runway (NASDAQ:RENT) stock is dropping almost 13% .
- Dare Bioscience (NASDAQ:DARE) shares are decreasing just about 10% after running higher yesterday on FDA approval for XACIATO.
- Bakkt (NYSE:BKKT) stock is declining over 9% after rallying on Wednesday.
- Cingulate (NASDAQ:CING) shares are dipping virtually 8% .
- Star Bulk Carriers (NASDAQ:SBLK) stock is slipping more than 7% .
- Auddia (NASDAQ:AUUD) shares close out our pre-market stock movers down over 7% after running higher yesterday on partnership news.
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.